Wellcome: 5 matters of urgency for the World Health Assembly 2019 Jeremy Farrar, director of Wellcome, discusses five global health topic areas to consider at the World Health Assembly (WHA) meeting, including antimicrobial drug resistance, the Sustainable Development Goals (SDGs), the Ebola epidemic, universal health coverage, and the global burden…

U.S. Department of Health and Human Services: Secretary Azar Meets with the Pasteur Institute “[On] May 18, 2019, Health and Human Services Secretary Alex Azar participated in a meeting with the Pasteur Institute. … [Officials] discussed the history of the Pasteur Institute and the continued collaboration between the Institute and…

STAT: Diagnostics are essential for universal health coverage to succeed Madhukar Pai, Canada research chair in epidemiology and global health at McGill University, director of McGill’s Global Health Programs, and director of the McGill International TB Centre; Catharina Boehme, chief executive officer at the Foundation for Innovative New Diagnostics (FIND);…

SciDev.Net: Eliminating malaria demands quality drugs Sivong Sengaloundeth, former deputy director of the Food and Drug Department in Lao PDR and champion of the Meds We Can Trust Campaign “…[The Greater Mekong Sub-region (GMS) is] coming to grips with a growing challenge to [eliminating malaria]: drug-resistant malaria. … Resistance to…

U.S. Department of Health and Human Services: Secretary Azar Attends G7 Health Ministerial Meeting and Participates in Bilateral Meetings This press release discusses HHS Secretary Alex Azar’s participation in bilateral meetings with health ministers during the G7 Health Ministerial Meeting in Paris and highlights his discussions on vaccines, global health…

The Conversation: Scientists alone can’t solve the antibiotic resistance crisis — we need economists too Laurence Roope, senior researcher for health economics at the University of Oxford; Richard Smith, professor of health economics and deputy pro vice chancellor at the University of Exeter; and Sarah Wordsworth, associate professor of health…

World Health Organization: Smarter research & development to tackle global health priorities “Today, WHO’s new Science Division launched an online resource to guide the development of new health products for which there are limited markets or incentives for research and development. An essential tool for realizing universal health coverage, the…

Newsweek: The Death Of Antibiotics: We’re Running Out Of Effective Drugs To Fight Off an Army of Superbugs “…There’s little in the pharmaceutical pipeline to replace the antibiotics to which bugs are becoming resistant. That’s because development of a new antibiotic runs about $2 billion and takes about 10 years…

Forbes: Building New Models To Support The Ailing Antibiotics Market Rick Bright, director of BARDA, a component of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services “…[C]hallenges sustaining a robust enterprise to address the growing threat of antibiotic resistance…

The Telegraph: Warning over global failure to act on deaths from drug-resistant TB “The spiraling number of deaths from drug-resistant tuberculosis (DR-TB) is set to cost the world economy nearly $20 billion annually. A report from the Economist Intelligence Unit warned that despite the fact that DR-TB is a huge…